Determinations of the content of selected triptanes in drug substance and pharmaceutical dosage forms using gas chromatography and densitometry in the presence of their degradation products

Authors

  • Anna Chyła Z Zakładu Farmacji Podstawowej i Stosowanej Narodowego Instytutu Leków w Warszawie
  • Monika Guzera Z Zakładu Farmacji Podstawowej i Stosowanej Narodowego Instytutu Leków w Warszawie
  • Aleksander P. Mazurek Z Zakładu Farmacji Podstawowej i Stosowanej Narodowego Instytutu Leków w Warszawie

Keywords:

naratriptan hydrochloride, sumatriptan TLC

Abstract

Two methods were developed for the determination of naratriptan hydrochloride and sumatriptan. Their degradation products indispensable for validation of the system were obtained by degrading the substances using acid (0.1 M hydrochloric acid), base (0.1 M sodium hydroxide), oxidising agent (30% hydrogen peroxide), heat (105˚C), and VIS irradiation as the degradation agents. The first method consisted in the use of gas chromatography with flame ionisation detector. The best results were acquired using as a stationary base a capillary column HP-1 (10 mm x 0,53 mm i.d. with a film thickness of 2.65 µm) and helium as a mobile phase. The initial temperature, speed of temperature increase, pressure of the carrier gas and internal references were selected. Calibration graphs were linear in the concentration range 50–350 µg/ml (naratriptan hydrochloride) and 10–200 µg/ml (sumatriptan). The second method consisted in the densitometric evaluation of the selected compounds (naratriptan hydrochloride and sumatriptan) in the tablets after former separation using a thin – layer chromatography. Ethyl acetate – methanol – ammonium hydroxide solution (19:2:1 v/v/v) was used as a mobile phase and optical densities were measured at 225 nm (naratriptan hydrochloride) and 226 nm (sumatriptan). Calibration graphs of naratriptan hydrochloride and sumatriptan were linear in the concentration ranges respectively 0.2 – 3 µg and 0.2 - 4µg per spot. The developed methods were successfully applied for determining naratriptan hydrochloride and sumatriptan in drug substances and pharmaceutical dosage forms (Naramig tablets, Imigran suppositories, Sumamigran tablets) and good repeatability and accuracy were proved. The obtained results were subject to analysis and compared with the reference methods, i.e. pharmacopeal HPLC methods.

Downloads

Download data is not yet available.

References

Diamond S, Nowe spojrzenie na leczenie migreny Medycyna po dyplomie 2001; 10:9: 46-56

Tipre DN, Vavia PR, Estimation of sumatriptan succinate in pharmaceutical dosage form by spectrophotometric and HPTLC methods: Indian Drugs 1999;36(8): 501-505, wg Analitycal Abstract 2000; 62(1);01G185

Roccholz G, Ahrens B, Konig F, Schutz HW, Shuz H, Seno H, Screening and Identification of Sumatriptan and Its Main Metabolite by Means of Thin-Layer Chromathography, Ultraviolet Spectroscopy amd Gas Chromatography / Mass Spectrometry Arzneimittelforschung. 1995; 45(9):941-946

Bebawy LJ, Moustafa AA, Abo-Talib NF, Stability-indicating methods for the determination of sumatriptan succinate J. Pharm. Biomed. Anal. 2003; 32;1123-1133

Singh S, Jain R, Stability indicating HPLC method for the determination of sumatriptan succinate in pharmaceutical preparation and its application in dissolution rate studies. Indian Drugs 1997; 34(9): 527-531

Shirsat VA, Gabne SY,High performance liquid chromatographic determination of sumatriptan succinate from pharmaceutical preparation Indian Drugs 1998; 35(7): 404-407

Avadhanulu AB, Srinivas JS, Anjaneyulu Y, Reverse-phase HPLC and colorimetric determination of sumatriptan in its drug form Indian Drugs 1996; 33(7): 334-337

Femenío-Font A, Merino V, Rodila V, López-Castelano A, High-performance liquid chromatographic determination of sumatriptan after in vitro transdermal diffusion studies J. Pharm. Biomed. Anal. 2005; 37(3): 621-626

Ge Z, Tessier E, Neirinck L, Zhu Z, High performance liquid chromatographic method for the determination of sumatriptan with fluoroscence detection in human plasma J.Chromatogr. B 2004; 806;229-303

Franklin M, Odontiadis J, Clement EM, Determination of sumatriptan succinate in human plasma by high-performance liquid chromatography with coulometric detection and utilization of solid –phase extraction J.Chromatogr. B Biomed. Appl.1996; 681(2): 416-420

Dunne M, Andrew P, Fully automated assay for the determination of sumatriptan in human serum using solid-phase extraction and high-performance liquid chromatography with electrochemical detection J.Chromatogr. B Biomed. Appl. 1996; 14(6) 721

Altria KD, Fibley SD, Quantative pharmaceutical analysis by capilary electrophoresis J. Liq. Chromatogr. 1993; 16(11): 2281-2292

Vishwanathan K, Baetlett MG, Stewart JT, Determination of antimigration compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry Rapid Commun. Mass Spectrom 2000; 14(3):168-172

Cheng KN, Redrup MJ, Borrow A, Williams PN, Validation of a liquid chromatographic tandem mass spectrometric method for the determination of suma- triptan in human biological fluids J. Pharm. Biomed. Anal. 1998; 17(3); 399-408

McLoughlin DA, Olah TV, Ellis JD, Gilbrt JD, Halpin RA, Quantation of the 5HT1D agonist MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry J. Chromatogr. A 1996; 726(1-2):115-124

Xu XH ,Bartlett MG, Stewart JT, Determination of degradation products of sumatriptan succinate using LC-MS and LC-MS-MSJ. Pharm. Biomed. Anal. 2001; 26(3): 367-377

Dulery BD, Petty MA, Schoun J, David M, Hubert ND, A method using a liquid chromatographic-electrospray-mass spectrometric assay for the determination of antimigraine compounds: preliminary pharmacokinetics of MDL 74,721, sumatriptan and naratriptan, in rabbit J. Pharm. Biomed. Anal. 1997; 15(7): 1009-1020

European Pharmacopeia Sixth Edition. Council of Europe, Strasbourg Cedex 2008; 4315-4317

British Pharmacopeia 2010. The Stationery Office, London 2009; 2026-2030: 3114-3118

The United States. Pharmacopeia USP 32. The United States Pharmacopeial Convention, Rockville 2009; 3639-3643:3039-3042

Altria KD, McLean R, Development and optimisation of generic micellar electrokineticcapilary chromatography method to support analysis of a wide range of pharmaceuticals and excipient J. Pharm. Biomed. Anal. 1998; 18: 807-813

Published

2012-03-30

How to Cite

Chyła, A., Guzera, M., & Mazurek, A. P. (2012). Determinations of the content of selected triptanes in drug substance and pharmaceutical dosage forms using gas chromatography and densitometry in the presence of their degradation products. European Journal of Clinical and Experimental Medicine, 10(1), 14–24. Retrieved from https://journals.ur.edu.pl/ejcem/article/view/12777